Company Filing History:
Years Active: 1999
Title: Karl Gewald: Innovator in Anticonvulsive Compounds
Introduction
Karl Gewald is a notable inventor based in Dresden, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with anticonvulsive activity. His work has implications for the treatment of various neurological conditions.
Latest Patents
Karl Gewald holds a patent for "Anticonvulsive 1-ar(alk)ylimidazolin-2-ones and process for making." This patent describes compounds that exhibit anticonvulsive activity, characterized by a specific chemical formula. The compounds include various residues and their pharmaceutically acceptable salts, showcasing Gewald's innovative approach to drug development.
Career Highlights
Karl Gewald is associated with Arzneimittelwerk Dresden GmbH, where he has contributed to the advancement of pharmaceutical research. His work has led to the creation of valuable compounds that can potentially improve the quality of life for individuals suffering from seizures and other related disorders.
Collaborations
Karl Gewald has collaborated with notable colleagues such as Hans-Joachim Lankau and Manfred Menzer. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical solutions.
Conclusion
Karl Gewald's contributions to the field of anticonvulsive compounds highlight his role as an innovative inventor. His patent and collaborative efforts reflect a commitment to advancing medical science and improving patient outcomes.